We've found
20,707
archived clinical trials in
Gastrointestinal
We've found
20,707
archived clinical trials in
Gastrointestinal
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Updated: 9/12/2017
A Open-Label Extension Study Of CP-690,550 As Maintenance Therapy In Patients With Crohn's Disease
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
Updated: 9/12/2017
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated: 9/12/2017
A Multi-strain Synbiotic Versus a Multi-strain Probiotic in Premature Infants
Updated: 9/12/2017
A Randomized Controlled Trial on a Multi-strain Synbiotic vs. a Multi-strain Probiotic on Fecal Colonization in the Very Low Birth Weight Infant
Status: Enrolling
Updated: 9/12/2017
Click here to add this to my saved trials
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
Updated: 9/13/2017
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated: 9/13/2017
Effects of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome (IBS)
Updated: 9/13/2017
The Effect of a Very Low Carbohydrate Diet on Symptoms of Irritable Bowel Syndrome: A Prospective Pilot Study
Status: Enrolling
Updated: 9/13/2017
Click here to add this to my saved trials
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
Updated: 9/13/2017
Randomized Control Trial Evaluating Optimal Patient Turning Procedures for Reducing Hospital Acquired Pressure Ulcers
Status: Enrolling
Updated: 9/13/2017
Optimal Patient Turning for Reducing Hospital Acquired Pressure Ulcers
Updated: 9/13/2017
Randomized Control Trial Evaluating Optimal Patient Turning Procedures for Reducing Hospital Acquired Pressure Ulcers
Status: Enrolling
Updated: 9/13/2017
Click here to add this to my saved trials
Postoperative Pain After Pediatric Umbilical Hernia Repair
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Postoperative Pain After Pediatric Umbilical Hernia Repair
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair
Updated: 9/14/2017
Postoperative Pain After Pediatric Umbilical Hernia Repair: a Randomized Clinical Trial of Ultrasound-guided Bilateral Rectus Sheath Blocks Versus Local Anesthetic Infiltration
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
The North American Pancreatitis Study
Updated: 9/14/2017
The North American Pancreatitis Study
Status: Enrolling
Updated: 9/14/2017
The North American Pancreatitis Study
Updated: 9/14/2017
The North American Pancreatitis Study
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Updated: 9/14/2017
Investigation of Two New 1-piece Ostomy Products in People With an Ileostomy or Colostomy
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Updated: 9/14/2017
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated: 9/14/2017
Effect of PEM Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in VLUs
Updated: 9/14/2017
Effect of Polidocanol Endovenous Microfoam (PEM) Treatment of Superficial Axial and Tributary Vein Reflux on Improvement of Wound Healing in Venous Leg Ulcers (VLUs)
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Study of Hepatocyte Growth Factor (HGF) Via Plasmid Vector to Improve Perfusion in Critical Limb Ischemia Patients With Peripheral Ischemic Ulcers
Updated: 9/14/2017
A Phase II Double-Blind, Randomized, Placebo-Controlled Study to Assess the Safety and Efficacy of AMG0001 to Improve Perfusion in Critical Limb Ischemia in Subjects Who Have Peripheral Ischemic Ulcers
Status: Enrolling
Updated: 9/14/2017
Click here to add this to my saved trials
Dietary Soy Isoflavones In Chronic Pancreatitis
Updated: 9/18/2017
Dietary Soy Isoflavones In Chronic Pancreatitis
Status: Enrolling
Updated: 9/18/2017
Dietary Soy Isoflavones In Chronic Pancreatitis
Updated: 9/18/2017
Dietary Soy Isoflavones In Chronic Pancreatitis
Status: Enrolling
Updated: 9/18/2017
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Click here to add this to my saved trials
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or T2DM and Suspected NAFLD
Updated: 9/18/2017
ORION - Effect of CCR2 and CCR5 Antagonism by Cenicriviroc on Peripheral and Adipose Tissue Insulin Sensitivity in Adult Obese Subjects With Prediabetes or Type 2 Diabetes Mellitus and Suspected Non-Alcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling
Updated: 9/18/2017
Click here to add this to my saved trials
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Updated: 9/21/2017
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated: 9/21/2017
Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site
Updated: 9/21/2017
Prevention of Relapse to Opioid Addiction Using Depot Naltrexone
Status: Enrolling
Updated: 9/21/2017
Click here to add this to my saved trials
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Updated: 9/21/2017
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Updated: 9/21/2017
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
Click here to add this to my saved trials
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Updated: 9/21/2017
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Updated: 9/21/2017
An Open-Label, Non-Randomized, Pharmacokinetic and Safety Study of Multiple Oral Doses of GW679769 in Subjects With Hepatic Impairment
Status: Enrolling
Updated: 9/21/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Early-Onset Sepsis Surveillance Study
Updated: 9/22/2017
Early-Onset Sepsis: an NICHD/CDC Surveillance Study
Status: Enrolling
Updated: 9/22/2017
Click here to add this to my saved trials